Gregory Vernier

Gregory Vernier currently serves as the Head of Business Development at Fab'entech and is a key member of the Management Committee, where he plays a pivotal role in shaping the company's strategic direction within the biopharmaceutical industry. Leveraging his dual expertise in life sciences and business, Gregory oversees the identification and execution of high-impact growth initiatives, including strategic partnerships, licensing agreements, and potential M&A opportunities. His leadership is instrumental in positioning Fab'entech as a leader in developing antibody-based therapeutics tailored for emergency response scenarios such as infectious disease outbreaks and bioterror threats.

In his role, Gregory combines deep scientific knowledge—spanning protein chemistry, molecular biology, and biophysics—with a keen understanding of go-to-market strategies and marketing management. This unique blend enables him to effectively translate cutting-edge biotechnological innovations into market-ready solutions, ensuring successful product launches and market access. His expertise in business development is complemented by a strong focus on global partnerships, fostering collaborations that accelerate the development and deployment of therapeutics for urgent medical needs.

Gregory's strategic initiatives often involve assessing emerging market trends and leveraging his extensive network within the lifesciences sector to facilitate licensing and distribution agreements. His leadership ensures that Fab'entech remains agile and responsive to the evolving landscape of infectious diseases and emergency medicine, ultimately advancing the company's mission to deliver life-saving therapeutics swiftly and effectively. Through his comprehensive approach, Gregory Vernier continues to drive Fab'entech’s growth and innovation at the intersection of science and business.